Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

382
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
382
Causality in Epidemiology01:21

Causality in Epidemiology

1.5K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.5K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.2K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

538
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
538
Social Exchange Theory01:26

Social Exchange Theory

347
As formulated by John Thibaut and Harold Kelley, Social Exchange Theory explains human relationships as economic-like exchanges that maximize rewards and minimize costs. This theory suggests that individuals engage in relationships to gain benefits and reduce burdens, similar to economic transactions. It has been widely applied to various types of relationships, including romantic, professional, and social interactions.Rewards and Costs in RelationshipsRelationship rewards include emotional...
347

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Trends in Utilization Management for Oncology Therapies Amongst US Commercial Health Plans: 2017-2024.

JCO oncology practice·2026
Same author

Mapping the Use of Real-World Evidence Across the EU Health Technology Assessment Regulation: Methodological Considerations, Challenges, and Opportunities for Harmonization.

Journal of market access & health policy·2026
Same author

Matching-adjusted indirect comparison of acalabrutinib versus ibrutinib in relapsed/refractory mantle cell lymphoma.

Journal of medical economics·2024
Same author

Quality-adjusted survival time without symptoms or toxicity of acalabrutinib with or without obinutuzumab in patients with treatment-naive chronic lymphocytic leukemia.

Leukemia & lymphoma·2023
Same author

Cost-effectiveness of acalabrutinib regimens in treatment-naïve chronic lymphocytic leukemia in the United States.

Expert review of pharmacoeconomics & outcomes research·2023
Same author

Considerations for the Utility of Real-World Evidence Beyond Trial Data in Advanced NSCLC: The Case of Frontline Tyrosine Kinase Inhibitors.

Cancer management and research·2022
Same journal

Flexible Survival Extrapolation with Blended Hazards: Accounting for Treatment Effect Waning in Health Technology Assessment.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

A Microsimulation Model for Chronic Kidney Disease Progression in Type 2 Diabetes Patients in the United States: Michigan Model for Diabetes-Chronic Kidney Disease Model.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

Cardiovascular Risk Estimation and Statin Adherence: A Historical Cohort Study.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

Taste or Scale? Methodological Approach to Health Preferences Comparison across Groups.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

Mind the Gap: Impact of New Labels on Public Perceptions and Calculated Risk of Adverse Outcomes after a Melanoma In Situ Diagnosis-A Secondary Analysis of an Online Randomized Experiment.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

A Metamodel-Based General-Purpose Autocalibration Tool for Simulation Models.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
查看所有相关文章

相关实验视频

Updated: Jan 9, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.4K

出版的成本效益分析何时包括社会成本? 一个经验分析,2013-2023年

Divya Patil1, Bengt Liljas2, Peter J Neumann1

  • 1Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

Medical decision making : an international journal of the Society for Medical Decision Making
|December 1, 2025
PubMed
概括
此摘要是机器生成的。

社会成本越来越多地被纳入成本效益分析 (CEA),但仍然不常见. 它们的纳入显著影响了成本效益比率,在以相关性和证据为指导时改善了价值评估.

关键词:
分析成本效益分析.社会成本是社会成本.社会视角 社会的视角

更多相关视频

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

786
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.7K

相关实验视频

Last Updated: Jan 9, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.4K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

786
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.7K

科学领域:

  • 卫生经济学 卫生经济学
  • 决策科学 决策科学 决策科学

背景情况:

  • 社会成本,包括生产力,运输和护理人员的时间,对于全面的健康经济评估至关重要.
  • 之前的分析已经强调了成本效益分析 (CEA) 中社会成本的代表性不足.

研究的目的:

  • 从2013年到2023年,追踪包括社会成本在CEA中的趋势.
  • 确定影响社会成本纳入的因素.
  • 评估社会成本对增量成本和增量成本效益比率 (ICER) 的影响.

主要方法:

  • 从塔夫斯医疗中心CEA注册表 (2013-2023) 中分析了7800个CEA.
  • 基于研究特征的社会成本纳入的评估.
  • 多变量后勤回归以确定研究特征和社会成本纳入之间的关联.
  • 评估社会成本对增量成本的影响,并为具有社会视角的研究提供ICER.

主要成果:

  • 在2013年至2023年期间,CEA中社会成本的纳入从19%上升到28%.
  • 生产力,运输和护理人员的时间是最常见的社会成本组件.
  • 在来自斯堪的纳维亚国家和荷兰的分析以及心理健康和免疫研究中观察到更高的包容率.
  • 纳入社会成本在72%的研究中降低了增量成本,在74%的研究中降低了ICER,有时超过了成本效益值.

结论:

  • 尽管增加不大,但社会成本在CEA中未得到充分利用,具有显著的地理,疾病特异性和基于人口的变化.
  • 纳入社会成本可以提高卫生干预措施的价值评估.
  • 纳入社会成本应该取决于背景,以相关性,可用的证据和决策需求为指导.